Vincerx Pharma, Inc. (VINC) Earnings
|
Expand Research on VINC
| Next EPS Date | 5/9/24 | EPS Growth Rate | +55.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -26.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/9/24 | Q124 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 4/1/24 | Q423 | -$0.23 | -$0.37 | +$0.14 | N/A | N/A | N/A |  | | Details | |
| 11/10/23 | Q323 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | N/A | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/23 | Q123 | -$0.68 | -$0.24 | -$0.44 | N/A | N/A | N/A | | | Details | |
| 3/21/23 | Q422 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A |
